Nomura Asset Management Co. Ltd. boosted its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 1.7% during the third quarter, according to its most recent filing with the SEC. The firm owned 47,432 shares of the company’s stock after buying an additional 770 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Thermo Fisher Scientific were worth $7,545,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Winslow Capital Management LLC bought a new position in Thermo Fisher Scientific during the third quarter worth approximately $299,455,000. Tesco Pension Investment Ltd bought a new position in Thermo Fisher Scientific during the third quarter worth approximately $137,726,000. FMR LLC boosted its position in Thermo Fisher Scientific by 11.3% in the second quarter. FMR LLC now owns 8,216,645 shares of the company’s stock worth $1,214,093,000 after buying an additional 834,858 shares during the last quarter. Carmignac Gestion boosted its position in Thermo Fisher Scientific by 23.3% in the second quarter. Carmignac Gestion now owns 4,046,550 shares of the company’s stock worth $597,918,000 after buying an additional 763,421 shares during the last quarter. Finally, Standard Life Investments LTD boosted its position in Thermo Fisher Scientific by 618.3% in the third quarter. Standard Life Investments LTD now owns 798,124 shares of the company’s stock worth $126,938,000 after buying an additional 687,018 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.
Thermo Fisher Scientific Inc (NYSE:TMO) traded down 2.5444% during trading on Wednesday, reaching $144.0199. 1,252,019 shares of the company’s stock were exchanged. Thermo Fisher Scientific Inc has a 52 week low of $119.75 and a 52 week high of $160.68. The stock has a market capitalization of $56.89 billion, a PE ratio of 28.7867 and a beta of 1.17. The stock has a 50-day moving average of $143.01 and a 200-day moving average of $150.40.
Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.06. The company earned $4.49 billion during the quarter, compared to the consensus estimate of $4.39 billion. Thermo Fisher Scientific had a return on equity of 14.95% and a net margin of 11.10%. Thermo Fisher Scientific’s revenue was up 8.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.80 EPS. On average, equities research analysts anticipate that Thermo Fisher Scientific Inc will post $8.25 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, January 16th. Shareholders of record on Thursday, December 15th will be given a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.41%. The ex-dividend date of this dividend is Tuesday, December 13th. Thermo Fisher Scientific’s dividend payout ratio is currently 12.00%.
TRADEMARK VIOLATION NOTICE: “Nomura Asset Management Co. Ltd. Has $7,545,000 Position in Thermo Fisher Scientific Inc (TMO)” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.com-unik.info/2017/01/11/nomura-asset-management-co-ltd-has-7545000-position-in-thermo-fisher-scientific-inc-tmo.html.
A number of research firms have recently commented on TMO. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Wednesday, December 14th. Goldman Sachs Group, Inc. (The) reiterated a “conviction-buy” rating and set a $168.00 target price (down from $170.00) on shares of Thermo Fisher Scientific in a report on Monday, December 12th. Leerink Swann reiterated a “buy” rating and set a $175.00 target price on shares of Thermo Fisher Scientific in a report on Sunday, November 20th. Bank of America Corporation set a $180.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Friday, October 7th. Finally, J P Morgan Chase & Co assumed coverage on shares of Thermo Fisher Scientific in a report on Thursday, September 22nd. They set an “overweight” rating and a $180.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Thermo Fisher Scientific presently has an average rating of “Buy” and an average price target of $165.22.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.